Alexis G. Malkin, OD

Study: Neurolenses significantly impact reading speed

FDA approves biosimilar product ranibizumab-eqrn for retinal diseases

Aerie doses first patient in COMET-3 study for DED treatment

EyeCare4Kids names new executive director